Adding 5-hydroxytryptamine receptor type 3 antagonists may reduce drug-induced nausea in poor insight obsessive-compulsive patients taking off-label doses of selective serotonin reuptake inhibitors: A 52-week follow-up case report

Michele Fornaro, Matteo Martino

研究成果: 雜誌貢獻文章同行評審

3 引文 斯高帕斯(Scopus)

指紋 深入研究「Adding 5-hydroxytryptamine receptor type 3 antagonists may reduce drug-induced nausea in poor insight obsessive-compulsive patients taking off-label doses of selective serotonin reuptake inhibitors: A 52-week follow-up case report」主題。共同形成了獨特的指紋。

Medicine & Life Sciences